Serologic response to hepatitis B vaccine in health care workers, Kermanshah, Iran

Journal of Research in Medical Sciences

Volumn 10, Issue 3, 2005, Pages 147-149

  Janbakhsh, Alireza ^a   Sayad, B ^a   Vaziri, S ^a   Aieni, P ^b  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Health care workers; Heberbiovac HB; Hepatitis B; Serologic response; Vaccine

Indexed keywords

HEBERBIOVAC HB; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HEALTH CARE PERSONNEL; HEPATITIS B; HIGH RISK POPULATION; HUMAN; INFECTION RISK; IRAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL HEALTH; POPULATION DISTRIBUTION; POPULATION RESEARCH; RISK FACTOR; SEROLOGY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VACCINATION;

EID: 24644433877     PISSN: 17351995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Robinson WS, Hepatitis B virus and Hepatitis D virus in: Mandell, Douglas and Bennett s. Principles and practice of Infectious Disease, 5th ed. Churchill Livingstone, Philadelphia 2000:1652-85.
2. Malekzadeh R. Viral Hepatitis in: Azizi, Hatami, Janghorbani. Epidemiology of communicable disease in Iran. 1th ed Eshtiagh, Tehran 2000:714-42.
3. Wood RC, Francis DP, White KE, et al. Risk factors for lack of detectable antibody following Hepatitis B vaccination on Minnesota health care workers. JAMA 1993;270:2935-9.
4. Lemon SM, Thomas DL. Vaccine to prevent viral hepatitis. N Eng J Med 1997;336:196-204.
5. Perera P, Perera B, Ggamage S. Seroconversion rate hepatitis B vaccination in healthy young adults and effect of a booster dose. http://slmaonline.org/cmj/CMJ4701/6.htm
6. Mahoney FJ. Update on diagnosis, management and prevention of Hepatitis B virus infection. Clin Microbiol Rev 1999; 12:351-6.
7. Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. What level of Hepatitis B antibody is protective? J Infect Dis 1999;179:489-92.
8. Louther J, Rivera P, Villa N, et al. Hepatitis B vaccination program at a New York city hospital: seroconversion and declination. Am J Infect Control.1998;26:423-7.
9. Sharifi MR, Ghorieshian SM. Evaluation of effect of hepatitis B vaccination in HCW in university of shahid Sadooghi, Yazd. Journal of Shahid Sadooghi University 1998;5(1):10-14.
10. Pahlavanzadeh H, Montazeri A, Yaaghoobi J, Evaluation of effect of HBV vaccine in HCW in Tabriz. 1992. http://www.hbi.dmr.or.ir/hosting/bioterrorism/computerized-books/ congereh/congzip.exe.pp1061
11. Ayazi F, Darvish Damavandi F, Shafiee M, Alibieghi P. Evaluation of immunologic response against HBV vaccine in HCW in Tehran http://www.hbi.dmr.or.ir/hosting/bioterrorism/computerized-books/ congerh/congzip.exe.pp1758
12. Moosavi Nasab SM, Mokhtari M, Mikaeeli J, Malekzadeh R. Evaluation of anti HbsAb titer in Shariati hospital. http://www.hbi.dmr.or.ir/hosting/bioterrorism/computerized-books/ congzip.exe.pp1642.
13. David J. Weber, William A Rutala. Vaccine for Health care workers in: Plotkin AS, Ornstein WA. Vaccine. 4th ed. Saunders 2004:1524-5.
14. Hadler SC, Francis DP, Maynard JE, et al. Long term immunogenicity and efficacy of Hepatitis B vaccine in homosexual men. N Eng J Med 1986;315:209-14
15. Brodrick A, Jonas MM. Hepatitis B and D viruses in: Figin, Cherry, Demmler, Kaplan Text book of pediatric infectious disease, WB.Saunders 2004:1876
16. Havlichek D, Rosenman K, Simms M, Guss P. Age-related hepatitis B seroconversion rates in HCWs. Am J Infest Control 1997;25(5):418-20.
17. Koff RS. Hepatitis vaccines. Infect Dis Clin North Am 2001;15:83-95
18. Koziel MJ, Siddiqui A. Hepatit B virus and Hepatitis Delta virus in: Mandell, Douglas and Bennett s principle and practice of infectious disease. 6th ed, Elsevier 2005:1884